Not provided
Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| NO1-AG-1-2100 | Other Grant/Funding Number | National Institute on Aging | |
| ZIAEY000401 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Iceland | OTHER |
Not provided
Not provided
Not provided
Not provided
5764 men and women in Iceland, aged 66 to 96 years entered the Ages Gene/Environment Susceptibility (AGES) - Reykjavik Study. Serum 25(OH)D was measured in 5,519 of all 5,764 (96%) participants at study entry in year 2002 through 2006. The main emphasis was on exploring whether pre-diagnostic serum levels of 25(OH)D were associated with survival after cancer diagnosis.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| AGES-Reykjavik participants | Exploring whether pre-diagnostic serum levels of 25(OH)D among older individuals living in Iceland were associated with survival after cancer diagnosis. We also assessed the risk of being diagnosed with cancer in association with 25(OH)D levels. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Overall survival | The association between pre-diagnostic 25(OH)D levels in cancer patients and overall survival | From date of diagnosis until death or censored at end of the follow-up (December 31, 2014) |
| Cancer survival | The association between pre-diagnostic 25(OH)D levels in cancer patients and cancer survival | From date of diagnosis until cancer death or censored at the end of the follow-up (December 31, 2014) |
| Measure | Description | Time Frame |
|---|---|---|
| Cancer diagnosis | The association between pre-diagnostic 25(OH)D levels and cancer risk | From date of blood draw (study entry) until cancer diagnosis, death or end of the observation period (December 31, 2014) whichever occurred first |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
In 1967, all 30,795 men and women living in the capital area of Iceland and born between 1907 and 1935 were invited by the Icelandic Heart Association to join a prospective cohort study. Approximately 19,000 attended the clinic at least once and became participants of the Reykjavik Study. Subsequently, in 2002, a random sample of the cohort comprising 5,764 men and women who were still alive in Iceland and aged 66 to 96 years entered the Ages Gene/Environment Susceptibility (AGES) - Reykjavik Study
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Johanna Torfadottir, PhD | University of Iceland | Principal Investigator |
Not provided
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 17351290 | Background | Harris TB, Launer LJ, Eiriksdottir G, Kjartansson O, Jonsson PV, Sigurdsson G, Thorgeirsson G, Aspelund T, Garcia ME, Cotch MF, Hoffman HJ, Gudnason V. Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics. Am J Epidemiol. 2007 May 1;165(9):1076-87. doi: 10.1093/aje/kwk115. Epub 2007 Mar 10. |
| Label | URL |
|---|---|
| Age, Gene/Environment Susceptibility-Reykjavik Study: Multidisciplinary Applied Phenomics | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Serum samples